메뉴 건너뛰기




Volumn 32, Issue 10, 2013, Pages

An updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment of fever during neutropenia in children with cancer

Author keywords

Biomarker; Child; Febrile neutropenia; Review; Risk

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GAMMA INTERFERON; GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; PROCALCITONIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

EID: 84891831404     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31829ae38d     Document Type: Review
Times cited : (48)

References (48)
  • 1
    • 0030701941 scopus 로고    scopus 로고
    • A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORT C studies
    • Hann I, Viscoli C, Paesmans M, et al. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORT C studies. Brit J Haem. 1997;99: 580-588.
    • (1997) Brit J Haem , vol.99 , pp. 580-588
    • Hann, I.1    Viscoli, C.2    Paesmans, M.3
  • 2
    • 84856107368 scopus 로고    scopus 로고
    • Advances in management of low-risk febrile neutropenia
    • Teuffel O, Sung L. Advances in management of low-risk febrile neutropenia. Curr Opin Pediatr. 2012;24: 40-45.
    • (2012) Curr Opin Pediatr , vol.24 , pp. 40-45
    • Teuffel, O.1    Sung, L.2
  • 3
    • 84865793102 scopus 로고    scopus 로고
    • Predicting infectious complications in neutropenic children and young people with cancer (IPD protocol)
    • PICNICC Collaboration
    • Phillips RS, Sutton AJ, Riley RD, et al.; PICNICC Collaboration. Predicting infectious complications in neutropenic children and young people with cancer (IPD protocol). Syst Rev. 2012;1: 8.
    • (2012) Syst Rev , vol.1 , pp. 8
    • Phillips, R.S.1    Sutton, A.J.2    Riley, R.D.3
  • 4
    • 84855894765 scopus 로고    scopus 로고
    • Systematic review and metaanalysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer
    • Phillips RS, Wade R, Lehrnbecher T, et al. Systematic review and metaanalysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer. BMC Med. 2012;10: 6.
    • (2012) BMC Med , vol.10 , pp. 6
    • Phillips, R.S.1    Wade, R.2    Lehrnbecher, T.3
  • 5
    • 0035100888 scopus 로고    scopus 로고
    • Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
    • Biomarkers Definitions Working Group
    • Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69: 89-95.
    • (2001) Clin Pharmacol Ther , vol.69 , pp. 89-95
  • 6
    • 0038611980 scopus 로고    scopus 로고
    • Diagnostic testing and prognosis: The randomised controlled trial in diagnostic research
    • Knottnerus J, ed.. London: Wiley-Blackwell;
    • Lijmer JG, Bossuy PM. Diagnostic testing and prognosis: the randomised controlled trial in diagnostic research. In: Knottnerus J, ed. The Evidence Base of Clinical Diagnosis: How to Do Diagnostic Research. London: Wiley-Blackwell; 2002.
    • (2002) The Evidence Base of Clinical Diagnosis: How to Do Diagnostic Research
    • Lijmer, J.G.1    Bossuy, P.M.2
  • 9
    • 77951637541 scopus 로고    scopus 로고
    • Predicting adverse events in children with fever and chemotherapy-induced neutropenia: The prospective multicenter SPOG 2003 FN study
    • Ammann RA, Bodmer N, Hirt A, et al. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol. 2010;28: 2008-2014.
    • (2010) J Clin Oncol , vol.28 , pp. 2008-2014
    • Ammann, R.A.1    Bodmer, N.2    Hirt, A.3
  • 10
    • 77950559031 scopus 로고    scopus 로고
    • Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia
    • Asturias EJ, Corral JE, Quezada J. Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia. Curr Oncol. 2010;17: 59-63.
    • (2010) Curr Oncol , vol.17 , pp. 59-63
    • Asturias, E.J.1    Corral, J.E.2    Quezada, J.3
  • 11
    • 70349588316 scopus 로고    scopus 로고
    • Significance of C-reactive protein during febrile neutropenia in pediatric malignancies
    • Avabratha KS, Rau AT, Venkataravanamma P, et al. Significance of C-reactive protein during febrile neutropenia in pediatric malignancies. Indian Pediatr. 2009;46: 797-799.
    • (2009) Indian Pediatr , vol.46 , pp. 797-799
    • Avabratha, K.S.1    Rau, A.T.2    Venkataravanamma, P.3
  • 13
    • 77953356360 scopus 로고    scopus 로고
    • Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia
    • Hatzistilianou M, Rekliti A, Athanassiadou F, et al. Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia. Inflamm Res. 2010;59: 339-347.
    • (2010) Inflamm Res , vol.59 , pp. 339-347
    • Hatzistilianou, M.1    Rekliti, A.2    Athanassiadou, F.3
  • 14
    • 79251606240 scopus 로고    scopus 로고
    • Increased T regulatory cells and decreased Th1 pro-inflammatory cytokines correlate with culture-positive infection in febrile neutropenia childhood oncology patients
    • Hodge G, Scott J, Osborn M, et al. Increased T regulatory cells and decreased Th1 pro-inflammatory cytokines correlate with culture-positive infection in febrile neutropenia childhood oncology patients. Cytokine. 2011;53: 286-288.
    • (2011) Cytokine , vol.53 , pp. 286-288
    • Hodge, G.1    Scott, J.2    Osborn, M.3
  • 15
    • 84891830519 scopus 로고    scopus 로고
    • Interleukin 6 and procalcitonin are good early markers of sepsis in children with febrile neutropenia
    • Boston MA: Wiley Liss Inc;
    • Kharya G, Dinand V, Prakash A, et al. Interleukin 6 and procalcitonin are good early markers of sepsis in children with febrile neutropenia. In: International Society of Paediatric Oncology, SIOP XXXXII Congress. Boston, MA: Wiley-Liss Inc; 2010: 953.
    • (2010) International Society of Paediatric Oncology SIOP XXXXII Congress , pp. 953
    • Kharya, G.1    Dinand, V.2    Prakash, A.3
  • 16
    • 79952405686 scopus 로고    scopus 로고
    • Procalcitonin adds to diagnosis, but does not reduce initial antibiotics in febrile neutropenic children
    • Lodahl D, Schrøder H. Procalcitonin adds to diagnosis, but does not reduce initial antibiotics in febrile neutropenic children. Dan Med Bull. 2011;58:A4233.
    • (2011) Dan Med Bull , vol.58
    • Lodahl, D.1    Schrøder, H.2
  • 17
    • 84891827084 scopus 로고    scopus 로고
    • Increased expression of inflammatory proteins predicts intensive care unit admission among children with fever and neutropenia
    • Mian A, Bhutta A, Prodhan P, et al. Increased expression of inflammatory proteins predicts intensive care unit admission among children with fever and neutropenia. Crit Care Med. 2009;37:A1-A567.
    • (2009) Crit Care Med , vol.37
    • Mian, A.1    Bhutta, A.2    Prodhan, P.3
  • 18
    • 80052430330 scopus 로고    scopus 로고
    • The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia
    • Miedema KG, de Bont ES, Elferink RF, et al. The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia. Support Care Cancer. 2011;19: 1593-1600.
    • (2011) Support Care Cancer , vol.19 , pp. 1593-1600
    • Miedema, K.G.1    De Bont, E.S.2    Elferink, R.F.3
  • 19
    • 77953278802 scopus 로고    scopus 로고
    • Serum derivative of reactive oxygen metabolites (d-ROMs) in pediatric hemato-oncological patients with neutropenic fever
    • Nishikawa T, Okamoto Y, Kodama Y, et al. Serum derivative of reactive oxygen metabolites (d-ROMs) in pediatric hemato-oncological patients with neutropenic fever. Pediatr Blood Cancer. 2010;55: 91-94.
    • (2010) Pediatr Blood Cancer , vol.55 , pp. 91-94
    • Nishikawa, T.1    Okamoto, Y.2    Kodama, Y.3
  • 21
    • 68549088911 scopus 로고    scopus 로고
    • Emesis predicts bacteremia in immunocompromised children with central venous catheters and fever
    • Richardson MW, Grewal SS, Visintainer PF. Emesis predicts bacteremia in immunocompromised children with central venous catheters and fever. Cancer. 2009;115: 3335-3340.
    • (2009) Cancer , vol.115 , pp. 3335-3340
    • Richardson, M.W.1    Grewal, S.S.2    Visintainer, P.F.3
  • 22
    • 46249112202 scopus 로고    scopus 로고
    • Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: A prospective, multicenter trial
    • Santolaya ME, Alvarez AM, Aviles CL, et al. Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial. Pediatr Infect Dis J. 2008;27: 538-543.
    • (2008) Pediatr Infect Dis J. , vol.27 , pp. 538-543
    • Santolaya, M.E.1    Alvarez, A.M.2    Aviles, C.L.3
  • 23
    • 33745883551 scopus 로고    scopus 로고
    • Interleukin-6, interleukin-8, interleukin-10, and C-reactive protein in febrile neutropenia in children with malignant diseases
    • Spasova MI, Terzieva DD, Tzvetkova TZ, et al. Interleukin-6, interleukin-8, interleukin-10, and C-reactive protein in febrile neutropenia in children with malignant diseases. Folia Med (Plovdiv). 2005;47: 46-52.
    • (2005) Folia Med (Plovdiv) , vol.47 , pp. 46-52
    • Spasova, M.I.1    Terzieva, D.D.2    Tzvetkova, T.Z.3
  • 24
    • 33846786790 scopus 로고    scopus 로고
    • Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia
    • Secmeer G, Devrim I, Kara A, et al. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia. J Pediatr Hematol Oncol. 2007;29: 107-111.
    • (2007) J Pediatr Hematol Oncol , vol.29 , pp. 107-111
    • Secmeer, G.1    Devrim, I.2    Kara, A.3
  • 25
    • 0026726237 scopus 로고
    • Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer
    • Katz JA, Mustafa MM, Bash RO, et al. Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer. Pediatr Infect Dis J. 1992;11: 708-712.
    • (1992) Pediatr Infect Dis J. , vol.11 , pp. 708-712
    • Katz, J.A.1    Mustafa, M.M.2    Bash, R.O.3
  • 26
    • 0027461821 scopus 로고
    • Fever and neutropenia in children with cancer: Diagnostic parameters at presentation
    • Riikonen P, Jalanko H, Hovi L, et al. Fever and neutropenia in children with cancer: diagnostic parameters at presentation. Acta Paediatr. 1993;82: 271-275.
    • (1993) Acta Paediatr , vol.82 , pp. 271-275
    • Riikonen, P.1    Jalanko, H.2    Hovi, L.3
  • 27
    • 34247623669 scopus 로고    scopus 로고
    • The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies
    • El-Maghraby SM, Moneer MM, Ismail MM, et al. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies. J Pediatr Hematol Oncol. 2007;29: 131-136.
    • (2007) J Pediatr Hematol Oncol , vol.29 , pp. 131-136
    • El-Maghraby, S.M.1    Moneer, M.M.2    Ismail, M.M.3
  • 28
    • 0141960348 scopus 로고    scopus 로고
    • Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection
    • Ammann RA, Hirt A, Lüthy AR, et al. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol. 2003;41: 436-443.
    • (2003) Med Pediatr Oncol , vol.41 , pp. 436-443
    • Ammann, R.A.1    Hirt, A.2    Lüthy, A.R.3
  • 29
    • 0028266346 scopus 로고
    • C-reactive protein: A valuable aid for the management of febrile children with cancer and neutropenia
    • Santolaya ME, Cofre J, Beresi V. C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia. Clin Infect Dis. 1994;18: 589-595.
    • (1994) Clin Infect Dis , vol.18 , pp. 589-595
    • Santolaya, M.E.1    Cofre, J.2    Beresi, V.3
  • 30
    • 33745071263 scopus 로고    scopus 로고
    • Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer
    • Kitanovski L, Jazbec J, Hojker S, et al. Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer. Eur J Clin Microbiol Infect Dis. 2006;25: 413-415.
    • (2006) Eur J Clin Microbiol Infect Dis , vol.25 , pp. 413-415
    • Kitanovski, L.1    Jazbec, J.2    Hojker, S.3
  • 31
    • 23844455201 scopus 로고    scopus 로고
    • Serum adenosine deaminase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukaemia
    • Hitoglou-Hatzi S, Hatzistilianou M, Gougoustamou D, et al. Serum adenosine deaminase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukaemia. Clin Exp Med. 2005;5: 60-65.
    • (2005) Clin Exp Med , vol.5 , pp. 60-65
    • Hitoglou-Hatzi, S.1    Hatzistilianou, M.2    Gougoustamou, D.3
  • 32
    • 0035879136 scopus 로고    scopus 로고
    • Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever
    • Santolaya ME, Alvarez AM, Becker A, et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol. 2001;19: 3415-3421.
    • (2001) J Clin Oncol , vol.19 , pp. 3415-3421
    • Santolaya, M.E.1    Alvarez, A.M.2    Becker, A.3
  • 33
    • 35148859385 scopus 로고    scopus 로고
    • Serial procalcitonin responses in infection of children with secondary immunodeficiency
    • Hatzistilianou M, Rekleity A, Athanassiadou F, et al. Serial procalcitonin responses in infection of children with secondary immunodeficiency. Clin Invest Med. 2007;30:E75-E85.
    • (2007) Clin Invest Med , vol.30
    • Hatzistilianou, M.1    Rekleity, A.2    Athanassiadou, F.3
  • 34
    • 0026749627 scopus 로고
    • Cytokine and acute-phase reactant levels in serum of children with cancer admitted for fever and neutropenia
    • Riikonen P, Saarinen UM, Teppo AM, et al. Cytokine and acute-phase reactant levels in serum of children with cancer admitted for fever and neutropenia. J Infect Dis. 1992;166: 432-436.
    • (1992) J Infect Dis , vol.166 , pp. 432-436
    • Riikonen, P.1    Saarinen, U.M.2    Teppo, A.M.3
  • 35
    • 2942516862 scopus 로고    scopus 로고
    • Circulating levels and promoter polymorphisms of interleukins-6 and 8 in pediatric cancer patients with fever and neutropenia
    • Lehrnbecher T, Fleischhack G, Hanisch M, et al. Circulating levels and promoter polymorphisms of interleukins-6 and 8 in pediatric cancer patients with fever and neutropenia. Haematologica. 2004;89: 234-236.
    • (2004) Haematologica , vol.89 , pp. 234-236
    • Lehrnbecher, T.1    Fleischhack, G.2    Hanisch, M.3
  • 36
    • 42149087153 scopus 로고    scopus 로고
    • Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk
    • Diepold M, Noellke P, Duffner U, et al. Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk. BMC Infect Dis. 2008;8: 28.
    • (2008) BMC Infect Dis , vol.8 , pp. 28
    • Diepold, M.1    Noellke, P.2    Duffner, U.3
  • 37
    • 0025236664 scopus 로고
    • The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel
    • Immunocompromised Host Society
    • Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel. J Infect Dis. 1990;161: 397-401.
    • (1990) J Infect Dis , vol.161 , pp. 397-401
  • 39
    • 21644438082 scopus 로고    scopus 로고
    • International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics
    • International Consensus Conference on Pediatric Sepsis
    • Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6: 2-8.
    • (2005) Pediatr Crit Care Med , vol.6 , pp. 2-8
    • Goldstein, B.1    Giroir, B.2    Randolph, A.3
  • 40
    • 23044514986 scopus 로고    scopus 로고
    • Ara-C fever and infections after highdose ara-C treatment in pediatric lymphoid malignancies
    • Ek T, Pinkava M, Abrahamsson J. Ara-C fever and infections after highdose ara-C treatment in pediatric lymphoid malignancies. J Pediatr Hematol Oncol. 2005;27: 364-369.
    • (2005) J Pediatr Hematol Oncol , vol.27 , pp. 364-369
    • Ek, T.1    Pinkava, M.2    Abrahamsson, J.3
  • 41
  • 43
    • 0034125698 scopus 로고    scopus 로고
    • Physiology and genetics of procalcitonin
    • Maruna P, Nedelníková K, Gürlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000;49(suppl 1):S57-S61.
    • (2000) Physiol Res , vol.49 , Issue.SUPPL. 1
    • Maruna, P.1    Nedelníková, K.2    Gürlich, R.3
  • 45
    • 84872746375 scopus 로고    scopus 로고
    • Identifying high-risk patients for severe infection in children with chemotherapyinduced febrile neutropenia: A new decision rule
    • (abstract)
    • Delebarre M, Dubos F, Macher E, et al. Identifying high-risk patients for severe infection in children with chemotherapyinduced febrile neutropenia: A new decision rule (abstract). Pediatr Blood Cancer. 2010;55: 823.
    • (2010) Pediatr Blood Cancer , vol.55 , pp. 823
    • Delebarre, M.1    Dubos, F.2    MacHer, E.3
  • 46
    • 84866622473 scopus 로고    scopus 로고
    • Role of procalcitonin in the diagnosis of severe infection in pediatric patients with fever and Neutropenia a systemic review and meta analysis
    • Lin SG, Hou TY, Huang DH, et al. Role of procalcitonin in the diagnosis of severe infection in pediatric patients with fever and Neutropenia-a systemic review and meta-analysis. Pediatr Infect Dis J. 2012;31:e182-e188.
    • (2012) Pediatr Infect Dis J. , vol.31
    • Lin, S.G.1    Hou, T.Y.2    Huang, D.H.3
  • 47
    • 78049292233 scopus 로고    scopus 로고
    • Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people
    • Phillips B, Wade R, Stewart LA, et al. Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people. Eur J Cancer. 2010;46: 2950-2964.
    • (2010) Eur J Cancer , vol.46 , pp. 2950-2964
    • Phillips, B.1    Wade, R.2    Stewart, L.A.3
  • 48
    • 84861714054 scopus 로고    scopus 로고
    • Updated systematic review and meta-analysis of the performance of risk prediction rules in children and young people with febrile neutropenia
    • Phillips RS, Lehrnbecher T, Alexander S, et al. Updated systematic review and meta-analysis of the performance of risk prediction rules in children and young people with febrile neutropenia. PLoS One. 2012;7:e38300.
    • (2012) PLoS One , vol.7
    • Phillips, R.S.1    Lehrnbecher, T.2    Alexander, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.